Sofosbuvir/velpatasvir/voxilaprevir | Search results | NICE

Showing 1 result for sofosbuvir/velpatasvir/voxilaprevir

Sort by

Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C (TA507)
Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.
Result type
Technology appraisal guidance
Published
21 February 2018
View recommendations for TA507
Show all sections
Sections for TA507